People: Intra-Cellular Therapies Inc (ITCI.OQ)
ITCI.OQ on NASDAQ Stock Exchange Global Select Market
13.08USD
22 May 2019
13.08USD
22 May 2019
Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$13.08
$13.08
Open
$12.72
$12.72
Day's High
$13.21
$13.21
Day's Low
$12.72
$12.72
Volume
56,348
56,348
Avg. Vol
111,466
111,466
52-wk High
$23.64
$23.64
52-wk Low
$10.24
$10.24
Halstead, Michael
Mr. Michael I. Halstead is the Senior Vice President, General Counsel, Secretary of Intra-Cellular Therapies, Inc. From July 2005 until December 2013, Mr. Halstead served in a number of leadership positions at Warner Chilcott plc. Most recently he was Senior Vice President, Corporate Development at Warner Chilcott where he directed the company’s corporate development, legal and human resources functions. Prior to that, Mr. Halstead was an attorney at the firm of Davis Polk & Wardwell. Mr. Halstead received his bachelor’s degree from Boston University and his Juris Doctor degree from Villanova University School of Law.
Basic Compensation
| Total Annual Compensation, USD | 683,000 |
| Restricted Stock Award, USD | 966,961 |
| Long-Term Incentive Plans, USD | -- |
| All Other, USD | 766,316 |
| Fiscal Year Total, USD | 2,416,280 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Exercisable | -- | -- |
| Unexercisable | -- | -- |
| Exercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Lawrence Hineline |
2,351,950 |
Mark Neumann |
-- |
Andrew Satlin |
2,018,330 |
Robert Davis |
2,008,300 |
Michael Halstead |
2,416,280 |
John Bardi |
-- |
As Of
31 Dec 2017